Kathleen Scott

Insider Reports History

Entity
Individual
Location
C/O Conatus Pharmaceuticals Inc., 16745 West Bernardo Drive, Suite 200, San Diego, CA
Signature
/s/ Kathleen Scott
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kathleen Scott:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARS Pharmaceuticals, Inc. Chief Financial Officer Common Stock 13.2K $211K $16.00 Aug 20, 2024 Direct
ARS Pharmaceuticals, Inc. Chief Financial Officer Stock Option (Right to Buy) 815K Aug 20, 2024 Direct
NKGen Biotech, Inc. Director Stock Option (right to buy) 300K Feb 12, 2024 Direct
Dermata Therapeutics, Inc. Director Stock Option (Right to Buy) 10K Jan 4, 2024 Direct

Insider Reports Filed by Kathleen Scott

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRY ARS Pharmaceuticals, Inc. Aug 20, 2024 3 -$181K 4 Aug 21, 2024 Chief Financial Officer
NKGN NKGen Biotech, Inc. Feb 12, 2024 1 $0 4 Feb 14, 2024 Director
DRMA Dermata Therapeutics, Inc. Jan 4, 2024 1 $0 4 Jan 5, 2024 Director
SPRY ARS Pharmaceuticals, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 Chief Financial Officer
NKGN NKGen Biotech, Inc. Sep 29, 2023 0 $0 3 Oct 10, 2023 Director
SPRY ARS Pharmaceuticals, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Chief Financial Officer
SPRY ARS Pharmaceuticals, Inc. Nov 29, 2022 1 $51.5K 4 Dec 1, 2022 Chief Financial Officer
SPRY ARS Pharmaceuticals, Inc. Nov 8, 2022 1 $0 4 Nov 10, 2022 Chief Financial Officer
SPRY ARS Pharmaceuticals, Inc. Nov 8, 2022 0 $0 3 Nov 10, 2022 Chief Financial Officer
DRMA Dermata Therapeutics, Inc. Oct 6, 2022 1 $0 4 Oct 7, 2022 Director
DRMA Dermata Therapeutics, Inc. Jul 7, 2022 1 $0 4 Jul 8, 2022 Director
DRMA Dermata Therapeutics, Inc. Apr 7, 2022 1 $0 4 Apr 8, 2022 Director
DRMA Dermata Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
DRMA Dermata Therapeutics, Inc. Aug 17, 2021 1 $0 4 Aug 17, 2021 Director
DRMA Dermata Therapeutics, Inc. Aug 12, 2021 0 $0 3 Aug 12, 2021 Director